You are here: Industry Insights > AstraZeneca

News List

Denmark suspends AZ/Oxford Covid-19 vaccination amid blood clot concerns pharmaceutical-technology
March 12, 2021
The Danish National Board of Health has temporarily paused the roll-out of the AstraZeneca/Oxford Covid-19 vaccine.
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets expresspharma
March 11, 2021
AstraZeneca Pharma India has received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the Drugs Controller General of India for Osimertinib 40mg/80mg film-coated tablets (Tagrisso).
NICE rejects AZ’s Lynparza for metastatic prostate cancer pharmatimes
March 10, 2021
The UK’s National Institute for Health and Care Excellence’s (NICE) appraisal committee has chosen not to recommend AstraZeneca’s (AZ) PARP inhibitor Lynparza for BRCA-positive metastatic prostate cancer.
AstraZeneca Advances Mass Global Rollout of COVID-19 Vaccine through COVAX americanpharmaceuticalreview
March 08, 2021
The first of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income countries across the world through the multilateral COVAX initiative, the first steps in fulfilling the Company’s efforts to provide broad and equitable access to ...
Aptamer Extends Collaboration with AstraZeneca contractpharma
March 08, 2021
Aptamer Group, the developer of Optimer reagents and therapeutics, has extended their current agreement with AstraZeneca.
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia pharmaceutical-technology
March 08, 2021
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.
Oxford study indicates AstraZeneca’s COVID-19 vaccine woks against Brazil variant: Report expresspharma
March 08, 2021
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the P1, or Brazilian variant, a source with knowledge of the study told Reuters.
Aptamer Group, AstraZeneca extend collaboration to explore next-gen drug delivery approaches expresspharma
March 05, 2021
The companies will evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.
US court rules in favour of AstraZeneca in Symbicort patent litigation pharmaceutical-technology
March 04, 2021
A US district court for the Northern District of West Virginia has decided in favour of AstraZeneca in a patent litigation lawsuit against Mylan Pharmaceuticals, which is now part of Viatris, and Kindeva Drug Delivery.
UK to receive 10 million AstraZeneca Covid vaccine doses from India: Report expresspharma
March 03, 2021
The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page